E-LIB Suche - Ergebnisse für: Burger, Jan A.

1

A multicenter study of venetoclax-based treatment for patie..:

Hampel, Paul J. ; Swaminathan, Mahesh ; Rogers, Kerry A....
Blood Advances. 8 (2024) 10 - p. 2342-2350 , 2024

Link: https://doi.org/10.1182/..

2

First‐line ibrutinib treatment in patients with chronic lym..:

Ghia, Paolo ; Owen, Carolyn ; Allan, John N....
HemaSphere. 8 (2024) 5 - p. , 2024

Link: https://doi.org/10.1002/..

3

P644: IBRUTINIB DOSE MODIFICATIONS FOR MANAGEMENT OF CARDIA..:

Stephens, Deborah ; R. Brown, Jennifer ; MA, Shuo...
HemaSphere. 7 (2023) S3 - p. e4171997 , 2023

Link: https://doi.org/10.1097/..

4

CLL-194 Ibrutinib for Treatment of Relapsed-Refractory Chro..:

Burger, Jan ; Ghia, Paolo ; Munir, Talha...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S322-S323 , 2023

Link: https://doi.org/10.1016/..

5

Chronic Lymphocytic Leukemia: Disease Biology:

Koehrer, Stefan ; Burger, Jan A.
Acta Haematologica. 147 (2023) 1 - p. 8-21 , 2023

Link: https://doi.org/10.1159/..

6

P485: AZACITIDINE, VENETOCLAX AND GILTERITINIB FOR PATIENTS..:

Short, Nicholas ; Macaron, Walid ; Dinardo, Courtney...
HemaSphere. 7 (2023) S3 - p. e535260f , 2023

Link: https://doi.org/10.1097/..

7

P645: IBRUTINIB FOR TREATMENT OF RELAPSED-REFRACTORY CHRONI..:

Ghia, Paolo ; Munir, Talha ; Burger, Jan...
HemaSphere. 7 (2023) S3 - p. e78258de , 2023

Link: https://doi.org/10.1097/..

8

Characteristics and Clinical Outcomes of Patients with Chro..:

Woyach, Jennifer A. ; Barr, Paul M. ; Kipps, Thomas J....
Cancers. 15 (2023) 2 - p. 507 , 2023

Link: https://doi.org/10.3390/..

9

Membranous nephropathy in chronic lymphocytic leukemia resp..:

Turcotte, Anna-Eve ; Glass, William F. ; Lin, Jamie S..
Leukemia Research Reports. 20 (2023) - p. 100377 , 2023

Link: https://doi.org/10.1016/..

10

Long‐term outcomes in patients with chronic lymphocytic leu..:

Gordon, Max J. ; Jones, Jade E. ; George, Binsah...
Cancer. 129 (2023) 14 - p. 2192-2200 , 2023

Link: https://doi.org/10.1002/..

11

A phase 2 study of nivolumab combined with ibrutinib in pat..:

Jain, Nitin ; Senapati, Jayastu ; Thakral, Beenu...
Blood Advances. 7 (2023) 10 - p. 1958-1966 , 2023

Link: https://doi.org/10.1182/..

12

Real and counterfeit cores: how feedback expands haloes and..:

Jahn, Ethan D ; Sales, Laura V ; Marinacci, Federico...
Monthly Notices of the Royal Astronomical Society. 520 (2023) 1 - p. 461-479 , 2023

Link: https://doi.org/10.1093/..

13

Prognostication of DNA Damage Response Protein Expression P..:

Griffen, Ti'ara L. ; Hoff, Fieke W. ; Qiu, Yihua...
International Journal of Molecular Sciences. 24 (2023) 6 - p. 5481 , 2023

Link: https://doi.org/10.3390/..

14

POSTER: CLL-194 Ibrutinib for Treatment of Relapsed-Refract..:

Burger, Jan ; Ghia, Paolo ; Munir, Talha...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S173 , 2023

Link: https://doi.org/10.1016/..

15

P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUT..:

Burger, Jan ; Kim, Ekaterina ; Sivina, Mariela...
HemaSphere. 7 (2023) S3 - p. e06532fc , 2023

Link: https://doi.org/10.1097/..